A detailed history of Us Bancorp \De\ transactions in Si Bone, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 37 shares of SIBN stock, worth $449. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Previous 25 48.0%
Holding current value
$449
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$12.9 - $17.11 $154 - $205
12 Added 48.0%
37 $0
Q2 2024

Aug 06, 2024

SELL
$11.93 - $16.34 $108,539 - $148,661
-9,098 Reduced 99.73%
25 $0
Q1 2024

May 07, 2024

SELL
$15.15 - $21.58 $54,327 - $77,385
-3,586 Reduced 28.22%
9,123 $149,000
Q4 2023

Feb 09, 2024

SELL
$15.75 - $21.38 $192,496 - $261,306
-12,222 Reduced 49.02%
12,709 $266,000
Q3 2023

Nov 03, 2023

SELL
$20.22 - $27.36 $35,870 - $48,536
-1,774 Reduced 6.64%
24,931 $529,000
Q2 2023

Aug 09, 2023

BUY
$19.39 - $28.9 $517,325 - $771,052
26,680 Added 106720.0%
26,705 $720,000
Q1 2023

May 09, 2023

SELL
$12.71 - $21.17 $1,334 - $2,222
-105 Reduced 80.77%
25 $0
Q4 2022

Feb 13, 2023

BUY
$11.23 - $19.44 $1,459 - $2,527
130 New
130 $1,000
Q2 2022

Aug 01, 2022

SELL
$12.05 - $22.74 $819 - $1,546
-68 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$18.75 - $24.8 $20,118 - $26,610
-1,073 Reduced 94.04%
68 $2,000
Q3 2021

Nov 10, 2021

BUY
$19.65 - $31.89 $8,449 - $13,712
430 Added 60.48%
1,141 $24,000
Q2 2021

Aug 05, 2021

BUY
$29.4 - $35.96 $10,907 - $13,341
371 Added 109.12%
711 $22,000
Q2 2020

Aug 07, 2020

BUY
$10.56 - $18.46 $3,590 - $6,276
340 New
340 $5,000
Q1 2019

May 08, 2019

SELL
$17.29 - $22.35 $8,472 - $10,951
-490 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$16.79 - $21.0 $8,227 - $10,290
490 New
490 $10,000

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $417M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.